0000920465-19-000025.txt : 20190131 0000920465-19-000025.hdr.sgml : 20190131 20190131184955 ACCESSION NUMBER: 0000920465-19-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190129 FILED AS OF DATE: 20190131 DATE AS OF CHANGE: 20190131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chawla Lakhmir S CENTRAL INDEX KEY: 0001646626 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 19557259 MAIL ADDRESS: STREET 1: 1960 KIRBY ROAD CITY: MCLEAN STATE: VA ZIP: 22101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_154897857940267.xml FORM 4 X0306 4 2019-01-29 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001646626 Chawla Lakhmir S C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Common Stock 2019-01-29 4 P 0 800 5.55 A 3059 D Common Stock 2019-01-29 4 P 0 1200 5.57 A 4259 D Common Stock 2019-01-30 4 P 0 800 5.5699 A 5059 D Common Stock 2019-01-30 4 P 0 200 5.57 A 5259 D /s/ Ryan Murr, as attorney-in-fact for Lakhmir S. Chawla 2019-01-31